CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Genes of the JAK-STAT pathway with significant differential expression in BM CD34+/lin- cells from 78 CP-CML patients at diagnosis vs. 12 months of nilotinib treatment.